Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...]
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2021-01-01
|
| Col·lecció: | Vaccines |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2076-393X/9/1/38 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|